Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy and of Immune Globulin
Intravenous (Human) IVIG-SN™ in subjects with kawasaki diseases.
Phase:
Phase 4
Details
Lead Sponsor:
Green Cross Corporation
Treatments:
Antibodies Aspirin Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous